PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
17-Feb-2023 Scientists at Macomics and University of Edinburgh Map Out the Discoveries of a New Class of Tumour Associated Immune Cells Revealing Opportunities to Develop Novel Cancer Treatments Macomics
17-Feb-2023 Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer ABIVAX
17-Feb-2023 Douglas GmbH: Strong start into the fiscal year - DOUGLAS reports double-digit growth in sales and profit in 1st quarter 2022/23 Douglas GmbH
17-Feb-2023 Surface Plasmon Resonance Market size is predicted to be valued at US$ 1807.7 million by 2032 | FMI MARKITWIRED
17-Feb-2023 Electronic Medical Records (EMR) Market is projected to reach a valuation of US$ 32.3 billion by 2033 | FMI MARKITWIRED
17-Feb-2023 Arthroscopy Procedure and Products Market is projected to increase at a CAGR of more than 7.7% through 2031 | FMI MARKITWIRED
17-Feb-2023 General Anesthesia Drugs Market is expected to reach US$ 6.7 Billion by 2032 | FMI Study MARKITWIRED
17-Feb-2023 Colorado Governor Polis Helps Agilent Break Ground on $725 Million Expansion of Manufacturing Operations in Frederick Businesswire
17-Feb-2023 Canmart Ends CEO Service Agreement; Akanda Approves Appointment of Director Businesswire
17-Feb-2023 Aptar Reports Fourth Quarter and Annual 2022 Results Businesswire
17-Feb-2023 Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023 Businesswire
17-Feb-2023 Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results Businesswire
17-Feb-2023 Cognex Announces Appointment of New Board Member and Retirement of Two Board Members Businesswire
17-Feb-2023 Fluor Selected for Agilent Life Sciences Facility Expansion in Colorado Businesswire
17-Feb-2023 Prothena to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023 Businesswire
17-Feb-2023 Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results Businesswire
17-Feb-2023 Blue Earth Diagnostics Announces Additional Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer Businesswire
16-Feb-2023 JVS Boston Names Kira Khazatsky as New CEO Businesswire
16-Feb-2023 New NUBEQA® (darolutamide) Subgroup Analyses from the Phase III ARASENS Trial in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients Presented at ASCO GU Businesswire
16-Feb-2023 Medical Germicidal Lamps Market is projected to grow at a CAGR of 9.1% through 2032 MARKITWIRED